Primary Address
3959 Broadway Suite 501
New York City, N.Y. 10032
Secondary Address
155 East 72 Street
New York City, NY 10021
NY Presbyterian-Columbia University Medical Center
Edward S. Harkness Eye Institute
Children’s Hospital of NY
212.305.5407
Pamela F. Gallin, M.D., F.A.C.S.
Clinical Professor of Ophthalmology
Director Emeritus, Pediatric Ophthalmology & Adult Strabismus
Available
Our friendly staff is dedicated to ensuring that every patient feel comfortable. Our office is handicapped accessible and has plenty of books and toys to make children feel at home. Dr. Gallin goes the extra mile and is always willing to spend as much time as she can with each patient, being sure to thoroughly answer all questions and concerns. Parents are our patients too and your needs are paramount to us. She runs all exams on her own and treats you like family. Following a visit, a written follow up to the referring physician and patient are sent. She truly loves what she does, and enjoys being involved in all steps of a patient's care. Dr. Gallin is a patient's advocate above all else, and is always willing to assist those who seek her help in any way that she can.
This exceptional quality of care and individual attention separates her from all other physicians.
“There's something special about Dr. Gallin. She takes the time. She has compassion. It's no wonder she was voted for 'Women Who Care'. She is more than just a doctor; she's a trusted friend.”
- Daniel
“Dr. Gallin is the most empathetic doctor I have ever had the pleasure of working with. She always takes her time when she is examining my children... they love the prizes they get when their appointments are finished!” - Justin
Dr Gallin performed Strabismus surgery on me. I never thought I would live life with perfect vision; she changed my world!”
- Jennifer
Saving a child’s vision—potentially life—now as simple as taking a photo on a phone
Technology is rapidly changing and we are on the fore front in diagnosing with a simple photograph.
What is this all about?
-
8 leading Children’s Hospitals (Stanford, Boston, Texas, Philadelphia, Los Angeles, Atlanta, Seattle, Cincinnati) named GoCheck Kids “Global Winner” of the Impact Pediatric Health Startup Pitch Competition at the SXSW conference.
-
American Association for Pediatric Ophthalmology and Strabismus (AAPOS) conference in Washington D.C., GoCheck Kids will officially announce the first iPhone app that helps pediatricians more easily and cost-effectively identify eye disease—simply by taking a child’s photo.
-
An FDA-cleared, disruptively-priced pediatric vision screener backed by tech titan and health philanthropist Marc Benioff, founder/CEO of Salesforce, is fundamentally changing the way our kids are protected from life-altering diseases that lead to blindness, learning shortfalls and sometimes even death.
-
Our technology has been proven with pediatricians nationally and clinically validated in peer-reviewed journals, and is recommended by leading ophthalmologists and pediatricians.
Why does this matter?
-
Vision impairment is the most prevalent disabling condition among U.S. children (CDC). 75 percent of kids under the age of six in the U.S. (18 million) risk permanent vision loss and vision-related learning setbacks as they do not receive annual screenings per the American Academy of Pediatrics’ guidelines.
-
Current screening solutions are cost-prohibitive for most hospitals - this impacts children in underserved communities the hardest, adversely affecting racially and ethnically minority populations. We are working with Health Systems and Head Start to address this issue.
-
Now pediatricians can benefit from the iPhone’s manufacturing scale to drastically reduce the cost of vision screening technology, by 50 percent on average. GoCheck Kids brings innovative health tech to even the most cash strapped hospitals and medical centers.
-
Until GoCheck Kids, the only solution was to purchase expensive proprietary hardware screeners —a complexity most pediatricians are forced to skip and rely on eye/wall charts which do not detect time-sensitive diseases early enough for treatment.